Detalhe da pesquisa
1.
Multiple primary dermatofibrosarcoma protuberans tumors in a single patient with chromosomal microarray analysis: A case report and review.
J Cutan Pathol
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548658
2.
Utility of GLI1 RNA Chromogenic in Situ Hybridization in Distinguishing Basal Cell Carcinoma From Histopathologic Mimics.
Mod Pathol
; 36(10): 100265, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37391171
3.
Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase.
Mol Ther
; 30(3): 1201-1214, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34813961
4.
The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication.
J Am Acad Dermatol
; 84(3): 587-595, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33352267
5.
The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Current and future approaches.
J Am Acad Dermatol
; 84(3): 597-604, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33352268
6.
Rapid manufacturing of non-activated potent CAR T cells.
Nat Biomed Eng
; 6(2): 118-128, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35190680
7.
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma.
Front Oncol
; 11: 669071, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34026647
8.
Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis.
JAMA Dermatol
; 157(1): 90-95, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33112366
9.
Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy.
CNS Drugs
; 34(2): 127-145, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31916100
10.
Diagnosis, Clinical Features, and Management of Patients With Granulomatous Cheilitis.
JAMA Dermatol
; 157(1): 112-114, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33175085
11.
Generalized granuloma annulare: A widespread response to limited application of compounded 2% topical tofacitinib.
JAAD Case Rep
; 6(10): 1113-1115, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33005718